Document Detail


Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
MedLine Citation:
PMID:  20580216     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: It is currently unclear whether the additive effects of a long-acting beta(2)-agonist (LABA) and the antimuscarinic tiotropium bromide (TIO) on resting lung function are translated into lower operating lung volumes and improved exercise tolerance in patients with chronic obstructive pulmonary disease (COPD).
METHODS: On a double-blind and cross-over study, 33 patients (FEV(1) = 47.4 +/- 12.9% predicted) were randomly allocated to 2-wk formoterol fumarate 12 microg twice-daily (FOR) plus TIO 18 microg once-daily or FOR plus placebo (PLA). Inspiratory capacity (IC) was obtained on constant-speed treadmill tests to the limit of tolerance (Tlim).
RESULTS: FOR-TIO was superior to FOR-PLA in increasing post-treatment FEV(1) and Tlim (1.34 +/- 0.42 L vs. 1.25 +/- 0.39 L and 124 +/- 27% vs. 68 +/- 14%, respectively; p < 0.05). FOR-TIO slowed the rate of decrement in exercise IC compared to FOR-PLA (Deltaisotime-rest = -0.27 +/- 0.40 L vs. -0.45 +/- 0.36 L, p < 0.05). In addition, end-expiratory lung volume (% total lung capacity) was further reduced with FOR-TIO (p < 0.05). Of note, patients showing greater increases in Tlim with FOR-TIO (16/26, 61.6%) had more severe airways obstruction and lower exercise capacity at baseline. Improvement in Tlim with FOR-TIO was also related to larger increases in FEV(1) (p < 0.05).
CONCLUSIONS: Compared to FOR monotherapy, FOR-TIO further improved effort-induced dynamic hyperinflation and exercise endurance in patients with moderate-to-severe COPD. These beneficial consequences were more likely to be found in severely-disabled patients with larger resting functional responses to the combination therapy. Trial registration: Clinicaltrials.gov Identifier: NCT00680056 [ClinicalTrials.gov].
Authors:
Danilo C Berton; Michel Reis; Ana Cristina B Siqueira; Adriano C Barroco; Luciana S Takara; Daniela M Bravo; Solange Andreoni; J Alberto Neder
Related Documents :
20920126 - Haemodynamic effects of proportional assist ventilation during high-intensity exercise ...
21825306 - Influence of physical activity on cardiorespiratory fitness in children after renal tra...
18018756 - Clinical use of heliox in asthma and copd.
10680096 - A comparison of autogenic drainage and the active cycle of breathing techniques in pati...
6512006 - Pharmacokinetic factors in the clinical use of tryptophan.
18248536 - Postural stability in altered and unaltered sensory environments following fatiguing ex...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2010-06-26
Journal Detail:
Title:  Respiratory medicine     Volume:  104     ISSN:  1532-3064     ISO Abbreviation:  Respir Med     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  1288-96     Citation Subset:  IM    
Affiliation:
Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil. dcberton@gmail.com
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00680056
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.
Next Document:  Surface plasmon resonance study of PNA interactions with double-stranded DNA.